Genmab | GEN - PE Price to Earnings


Genmab reported 17.14 in PE Price to Earnings for its fiscal quarter ending in December of 2025.





Pe Change Date
Agios Pharmaceuticals 3.56 0.68 Sep/2025
Almirall 79.43 0.3 Dec/2025
Amarin 91.05 88.3 Jun/2023
Amgen 25.31 15.82 Dec/2025
argenx SE 43.02 11.67 Dec/2025
AstraZeneca 27.29 5.8 Dec/2025
Bayer 5.93 0.68 Sep/2025
BioMarin Pharmaceutical 19.24 0.21 Dec/2025
Demant 27.46 7.1 Dec/2025
Exelixis 602.31 586.25 Dec/2025
Fresenius Medical Care 8.71 1.86 Dec/2025
Galapagos 3.14 50.78 Dec/2025
Genmab 17.14 4.39 Dec/2025
GlaxoSmithKline 11.15 0.29 Dec/2025
GN Store Nord 16.87 3.58 Sep/2025
GRIFOLS 16.81 28.19 Sep/2025
Hikma Pharmaceutical 10.43 3.72 Dec/2025
Lonza 34.34 2.58 Dec/2025
Merck 20.56 7.18 Dec/2025
Novartis 17.85 2.11 Dec/2025
Regeneron Pharmaceuticals 18.11 2.91 Dec/2025
Roche Holding 16.09 3.51 Dec/2025
Sanofi 11.99 1.58 Dec/2025
UCB 29.7 5.52 Dec/2025